Victor Dodig: CIBC President & CEO

Victor Dodig holds a Bachelor of Commerce from the University of Toronto. He earned an MBA from Harvard University and was a Baker Scholar. Victor also holds a Diploma from the Institut d’Etudes Politiques in Paris, France. 

Among his various professional positions was as management consultant with McKinsey and Company from 1994 to 1997. He also worked at Kraft General Foods Inc. At one point he was the Managing Director and Chief Executive Officer of Merrill Lynch Investment Managers Canada. 

Before Victor joined Canada Imperial Bank of Commerce (CIBC) he was Managing Director and Chief Executive Officer in Canada for UBS Global Asset Management. In 2005 he joined CIBC as Executive Vice-President, CIBC Wealth Management. 

Victor was appointed Executive Vice-President, Retail Distribution in 2007. In this position  he led the bank’s retail banking distribution and sales team. In 2007, Victor was named Group Head, Wealth Management, being responsible for the bank’s brokerage, private wealth, and asset management businesses in Canada and the US.

In September 2014, Victor became head of CIBC, being appointed President and Chief Executive Officer and member of CIBC’s Board of Directors. 

Donald A. Guloien: Manulife Chief

Donald A. Guloien graduated from the University of Toronto with a Bachelor of Commerce degree. Donald joined Manulife Financial, one of the largest insurance and financial services companies in the world, in 1981 as a research analyst. His talent enabled him to quickly move through a number of strategic and marketing positions in both the Canadian and U.S. Divisions.

Donald became Vice President, US Individual Business in 1990. He was responsible for the operations of Manulife’s individual insurance and annuity business in the United States. From 1994 to 2001, he headed the company’s Business Development unit. Donald led a number of key acquisitions, divestures and strategic initiatives, including: the merger of Manulife with North American Life Assurance Company; sale o f Manulife’s U.K. business; Manulife’s conversion from a mutual life insurance company to a publicly traded stock company; and its entry into Japan.

Donald rose further through the ranks and became the Chief Investment Officer from 2001 to 2009. He became the CEO in 2009 under very tough economic and business conditions. Donald took the controversial actions of going to the market for $2.5 billion in common equity in November, 2009 and slashed the dividend in half in August, 2009.

A true leader, Donald took the painful but necessary actions to keep Manulife healthy and continue to experience solid returns.

Dr. Sagun Tuli’s Distinguished Career in Neurosurgery and Spinal Care

An experienced neurosurgeon and specialist in complex spinal cases, Dr. Sagun Tuli has held instructor responsibilities with Harvard Medical School for the past decade. The only female spine surgeon employed within the Harvard system, she has served as Assistant Professor since 2005. She has additionally practiced at the Center for Advanced Brain and Spine Surgery in Natick since 2011, assisting patients with diverse infectious, traumatic, neoplastic, and degenerative conditions.

Originally from India, Sagun Tuli, M.D. pursued her higher education in Canada, initially through an undergraduate degree in the sciences at the University of Toronto. Reflecting sustained academic achievement, she received a Marianno A. Elia Scholarship, a University Women’s Club Year II Book Prize in Sciences, and a Dean’s Honor Award during this time. Beginning medical studies at the University of Toronto in 1989, Dr. Tuli earned several prestigious medical scholarships and entrance into the Alpha Omega Alpha Honor Medical Society.

From 1993 to 2000, Dr. Sagun Tuli completed a neurosurgery residency at the University of Toronto, additionally earning a Harvard School of Public Health M.Sc. in Epidemiology in 1998. She became a Fellow of the Royal College of Surgeons of Canada while still engaged in residency training, also achieving award recognition from the Congress of Neurological Surgeons and the Hospital for Sick Children. Following a spine surgery fellowship at the Brigham and Women’s Hospital in Boston, Dr. Sagun Tuli accepted a position as Attending Physician and Associate Surgeon from.

Over the past decade, Dr. Tuli has achieved numerous academic publications and made regular public presentations. In 2007, she notably spoke before the Department of Neurosurgery, Children’s Hospital and Brigham and Women’s Hospital, on the topic “Methylprednisilone - the two edged sword.”